Home›Compare›Defy Medical vs Lttl

Defy Medical vs Lttl: Which Is Better?

Head-to-head comparison of Defy Medical and Lttl based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Defy Medical scores higher overall in our independent evaluation (71.9/100 vs 66.2/100), leading on trust & safety, experience, product range, reputation. Lttl comes out ahead on value. Lttl has the lower entry price (from $79/mo vs $150/mo), so the better value depends on which treatment you need.

Physician-led telemedicine hormone clinic offering TRT, women's HRT, peptides, GLP-1s, and sexual-health treatments through its own 503B pharmacy.

Visit Defy Medical
66
Lttl
Good

Lttl is a 2026-launched telehealth brand selling compounded GLP-1s, microdosed GLP-1s and a wide menu of longevity compounds at flat, dose-independent prices.

Visit Lttl

Score Breakdown

DimensionDefy MedicalLttl
Overall Score71.9/100 ✓66.2/100
Trust & Safety30%72/100 ✓60/100
Value25%60/10080/100 ✓
Experience20%78/100 ✓62/100
Product Range15%78/100 ✓72/100
Reputation10%80/100 ✓50/100

At a Glance

Founded20112026
HeadquartersTampa, FLWoodland Hills, CA
Publicly tradedNoNo
Treatment categories32
Treatments listed410
Starting price$150/mo$79/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryDefy MedicalLttl
Weight Loss / GLP-1$150–$250
GLP-1 Weight Loss (Semaglutide/Tirzepatide)
$89
Compounded Semaglutide

Defy Medical

+15 years in operation (founded 2011) — one of the longest-running cash-pay hormone-therapy telehealth brands, with a named Medical Director (Dr. Justin Saya)
+Trustpilot rating of 4.8/5 across 4,144 reviews, and the company responds to 94% of negative reviews, typically within 24 hours
+Broad treatment range from a single provider — TRT, women's HRT, peptides, GLP-1s, sexual dysfunction, and hair loss — dispensed through its own 503B-registered pharmacy with labs required before prescribing
−Pricing is not published on the website; patients must complete a roughly $250 consult before learning treatment costs, a transparency gap versus competitors that post pricing upfront
−Some patients report delays of a week or more between consult and medication fulfillment
−Mobile app quality lags the web experience, per patient feedback
Read the full Defy Medical review →

Lttl

+Among the lowest advertised compounded GLP-1 prices reviewed: semaglutide from $89/mo, tirzepatide from $139/mo, same price at every dose
+No membership fee, month-to-month plans, free expedited shipping
+Wide longevity menu (NAD+ in three formats, sermorelin, glutathione, MIC-B12, methylene blue, L-carnitine) alongside microdosed GLP-1s
−Launched in 2026, with about 10 Trustpilot reviews, all 5-star: too few to judge service quality
−Marketing claims such as 'trusted by 100k+ Americans' and a 'Best Provider of 2026' badge are hard to reconcile with the brand's age
−'Plans start at' pricing is shown next to an 'up to $140 off your first month' banner, so the ongoing price after the first month is unclear
Read the full Lttl review →

Defy Medical vs Lttl — FAQ

Is Defy Medical better than Lttl?

▾

Defy Medical scores higher overall in our independent evaluation (71.9/100 vs 66.2/100), leading on trust & safety, experience, product range, reputation. Lttl comes out ahead on value. Lttl has the lower entry price (from $79/mo vs $150/mo), so the better value depends on which treatment you need.

Is Defy Medical or Lttl cheaper?

▾

Lttl has the lower starting price (from $79/mo vs $150/mo for Defy Medical). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do Defy Medical and Lttl both offer?

▾

Both platforms treat Weight Loss / GLP-1. Defy Medical covers 3 treatment categories total and Lttl covers 2.

Still deciding?